The chemical class known as LOC100041102 Inhibitors encompasses a series of compounds specifically designed to target and inhibit the activity of the gene product encoded by LOC100041102. Discovered through comprehensive genomic research, LOC100041102 plays a crucial role in a variety of cellular processes, with its function being notably context-dependent. This means that the gene's role can significantly vary depending on the specific cellular environment and the external stimuli it encounters. Inhibitors targeting LOC100041102 are meticulously developed to selectively bind to the proteins or enzymes that result from this gene's expression. This selective interaction is key to the functionality of these inhibitors, as it directly impacts the biochemical pathways in which the LOC100041102 gene product is involved. The primary aim of these inhibitors is to modulate the activity of this gene product, thereby influencing the associated cellular mechanisms and processes.
The development of LOC100041102 Inhibitors is a complex and interdisciplinary task, involving elements from molecular biology, chemistry, and bioinformatics. The process begins with an in-depth understanding of the structure and function of the LOC100041102 gene product. Techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational molecular modeling play crucial roles in this stage, providing detailed insights into the target molecule. This comprehensive understanding is vital for the rational design of inhibitors that are effective in their interaction and exhibit a high level of specificity for their target. These inhibitors are typically small molecules, designed to efficiently penetrate cellular membranes and to establish a stable and potent interaction with their target. The molecular design of these inhibitors is carefully optimized, ensuring strong interactions with the target molecule, which often involves the formation of hydrogen bonds, hydrophobic interactions, and van der Waals forces. The effectiveness of these inhibitors is evaluated through various biochemical assays in vitro. These assays are critical in assessing the inhibitors' potency, specificity, and overall interaction dynamics, providing key insights into their behavior under controlled experimental conditions. Such research is essential for advancing our understanding of the inhibitors' mechanism of action and for further investigations into their potential impact on cellular pathways and functions influenced by LOC100041102.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A nucleoside analog that can incorporate into DNA and RNA, leading to hypomethylation of DNA and potentially affecting gene expression. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Mimics the 3'-end of an aminoacyl-tRNA and causes premature chain termination during translation, leading to reduced protein levels. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Intercalates into DNA, disrupting topoisomerase-II-mediated DNA repair and affecting transcription and replication processes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that alters chromatin structure and can modulate gene expression patterns. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
A pyrimidine analog that gets incorporated into RNA, disrupting RNA processing and function, potentially affecting gene expression. | ||||||
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | $265.00 | 9 | |
A phosphate ester that can inhibit topoisomerase II and protein phosphatases, potentially affecting the phosphorylation status of transcription factors and gene expression. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Inhibits DNA polymerase α and δ, leading to S phase arrest and potentially affecting gene transcription indirectly. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
An inhibitor of G9a histone methyltransferase, potentially affecting the methylation status of histones and gene expression. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Inhibits eukaryotic initiation factor 4A, a component of the translation initiation complex, potentially reducing protein synthesis. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and prevents the transcription elongation by RNA polymerase, which could nonspecifically inhibit gene expression. | ||||||